The subject of the contract includes the supply of medicinal products – 91 parts described in detail in Appendix 2 to the Terms of Reference.

Cetuximab

Atezolizumab

Afatinib

Nintedanib

Alectinib

Ceritinib

Brigatinib

Durwalumab

BCG Vaccinum

Lorlatinib

Entrectinibum

panitumumab

Cemiplimab

trastuzumab

Lapatinib

Pertuzumab

Palbocyclib

Ribocyclib

Trastuzumab emtansin

Abemaciclib

Alpelisyb

Sacytuzumab gowitekan

Aflibercep

Talazoparyb

Pixantrone dimaleate

Polatuzumab wedotyny

Tafasitamabum

Ibrutynib

Obinutuzumab

Dasatinib

Nilotinib

Bosutynib

Ponatinib

Trifluridine + Typiracil

Olaparyb

Niraparib

Pomalidomide

Daratumumab

Karfilzomib

Iksazomib

ELOTUZUMABUM

Enzalutamide

APALUTAMIDE

Darolutamide

Ipilimumabum

Kabazazitaxel

Ramucyrumab

Blinatumomab

Inotuzumab ozogamycin

Brentuksymab wedotyny

Akalabrutynib

Venetoclaks

Ruksolitynib

Fedratinib

Paklitaxel with albumin

Nivolumab

Elthrombopag

Romiplostym

Awatrombopag

MIDOSTAURINE

Gemtuzumab ozogamycyny

Gilterytynib

AZACITIDINE

Siltuximab

denosumab

Luspatercept

Pembrolizumab

Interferon β-1a

Glatiramer acetate

:Fumaran dimetylu

Peginterferon-β-1a

Teryflunomid

Ofatumumab

ozanimod

ponesimod

Siponimod

Fingolimod

Crisotinib

natalizumab

Okrelizumab

Cladribine

Alemtuzumab

Interferon β-1a

:Interferon β-1b

:Immunoglobulinum humanum

Netupitantum + Palonosetroni hydrochloridum

Epirubicin

AZACITIDINE

OSIMERTINIB

Rituximab

denosumab